ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Oral Potentially Malignant Disorders · Understanding the disease

Where in the world is oral potentially malignant disorders most common?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Oral Potentially Malignant Disorders Answer length: short, citable
Quick answer

Oral Potentially Malignant Disorders is not evenly distributed: the highest-burden regions are India, Bangladesh, Pakistan, Sri Lanka, Nepal and Papua New Guinea & Pacific Islands. In 2022 there were no global case count — these are precancerous lesions, not registered cancers worldwide (prevalence of oral potentially malignant disorders varies from under 1% to over 5% in high-exposure adult populations), with marked country-to-country variation driven by local exposures such as tobacco, areca nut, oncogenic viruses, ultraviolet radiation and occupational carcinogens.

In detail

The regional pattern matters clinically. A patient from India may present with a different risk-factor profile and a different stage distribution than a patient from a low-incidence country, which changes both the differential diagnosis and the pretreatment work-up.

All incidence figures on this site are age-standardised rates or absolute case counts from GLOBOCAN 2022 and its subsite analyses. They describe populations, not individual risk.

  • India: Very high prevalence of leukoplakia, oral submucous fibrosis and oral cancer. Tobacco and areca nut account for about 70–80% of the 143,759 oral cancer cases recorded in 2022.
  • Bangladesh, Pakistan, Sri Lanka, Nepal: Widespread gutka, khaini, betel quid and areca nut use; smokeless tobacco consumption has been increasing since 2000.
  • Papua New Guinea & Pacific Islands: Areca nut chewing is associated with the world’s highest female oral cavity cancer ASR (8.1/100,000) and high rates of oral mucosal disease.
  • Taiwan region of China & South-East Asian communities: Betel quid chewing is associated with oral submucous fibrosis, leukoplakia and buccal mucosa cancer; cessation programmes reduce risk over time.
  • Migrant communities worldwide: Areca nut and smokeless tobacco habits often continue after migration, so clinicians in Europe, North America and Australia should ask specifically about chewing products.

What this means in practice: this answer is part of the “Understanding the disease” section of the Oral Potentially Malignant Disorders topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about oral potentially malignant disorders

See all 13 questions in this topic →

Sources for this answer

  1. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  2. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  3. Global Cancer Facts & Figures, 5th Edition (GLOBOCAN 2022 tables) American Cancer Society · 2024
  4. Smokeless Tobacco and Oral Cancer in Global Perspective New England Journal of Medicine · 2026 · More than 360 million users of smokeless tobacco; ~120,000 oral cancer cases attributable to smokeless tobacco, areca nut or both in 2022.
  5. Oral cancer burden and mortality in India: a GLOBOCAN 2022 analysis with regional comparison ecancermedicalscience · 2026 · 143,759 new oral cancer cases and 79,979 deaths in India in 2022.
  6. IARC Monographs on the Identification of Carcinogenic Hazards to Humans (tobacco, areca nut, UV radiation, EBV, HPV) International Agency for Research on Cancer / WHO · 2024
  7. Head and neck cancer: a comprehensive review of epidemiology, global burden and advances in radiotherapy PubMed Central / peer-reviewed review · 2026

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat is oral potentially malignant disorders? Next question →What are the risk factors for oral potentially malignant disorders?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.